Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
09/12/2013 | US20130237696 Vascular therapeutics |
09/12/2013 | US20130237589 Aptamer therapeutics useful in the treatment of complement-related disorders |
09/12/2013 | US20130237588 Vascular therapeutics |
09/12/2013 | US20130237587 Mir 204, mir 211, their anti-mirs, and therapeutic uses of same |
09/12/2013 | US20130237586 DELIVERY OF dsRNA TO ARTHROPODS |
09/12/2013 | US20130237585 Modulation of dystrophia myotonica-protein kinase (dmpk) expression |
09/12/2013 | US20130237584 CANCER THERAPY USING Bcl-XL-SPECIFIC siNA |
09/12/2013 | US20130237458 Method of adding a DBR by primer extension |
09/12/2013 | US20130237446 Use of the Genes in the Hog, Ras and cAMP Pathway for Treatment Of Fungal Infection |
09/12/2013 | US20130237442 Methods and Compositions for Diagnosis of Non-Viable Early Pregnancy |
09/12/2013 | US20130236968 Multifunctional copolymers for nucleic acid delivery |
09/12/2013 | US20130236967 Modifications for Antisense Compounds |
09/12/2013 | US20130236964 Methods, nucleic acid constructs and cells for treating neurodegenerative disorders |
09/12/2013 | US20130236958 Viral expression plasmids for production of proteins, antibodies, enzymes, virus-like particles and for use in cell-based assays |
09/12/2013 | US20130236957 Expression vector and methods of producing high levels of proteins |
09/12/2013 | US20130236956 Nucleic acid fragments from a ribosomal protein promoter for enhancing gene expression |
09/12/2013 | US20130236954 Method for Isolation of Transcription Termination Sequences |
09/12/2013 | US20130236948 Recombinant microorganisms and uses thereof |
09/12/2013 | US20130236942 Production of acetyl-coenzyme a derived isoprenoids |
09/12/2013 | US20130236930 Process for producing igf-1 polypeptides |
09/12/2013 | US20130236911 Hemokinin-1 receptor and hemokinin-1-derived peptide |
09/12/2013 | US20130236903 Automatic necleic acid purification apparatus and method for aerosol-protecting |
09/12/2013 | US20130236891 Method and composition for the treatment, prevention, and diagnosis of cancer containing or derived from cancer stem cells |
09/12/2013 | US20130236536 Oligonucleotide Analogues Incorporating 5-Aza-Cytosine Therein |
09/12/2013 | US20130236479 Antigen |
09/12/2013 | DE19681598B3 Vorrichtung und Verfahren zur elektrostatischen Endothelzellen-Ansiedlung und DNA-Transfektion Apparatus and method for electrostatic endothelial cell colonization and DNA transfection |
09/12/2013 | DE112011104462T5 Nematodenresistente transgene Pflanzen Nematode-resistant transgenic plants |
09/12/2013 | DE112011104038T5 Verfahren zur Herstellung synthetischer Promotoren mit definierter Spezifität Process for the preparation of synthetic promoters with defined specificity |
09/12/2013 | CA2773505A1 Isothermal dna amplification |
09/11/2013 | EP2636748A1 Amino sugar-containing glucan, method for producing same and use of same |
09/11/2013 | EP2636746A1 A novel drug delivery system based on JCV-VLP |
09/11/2013 | EP2636745A1 Improvement of the kernel productivity of plants through the modulation of glutamine synthetase activity |
09/11/2013 | EP2636744A1 Mutant of propionyl-CoA transferase from Clostridium propionicum and preparing method for PLA or PLA copolymer using the same |
09/11/2013 | EP2636743A1 Pestivirus species |
09/11/2013 | EP2636742A1 Induction of exon skipping in eukaryotic cells |
09/11/2013 | EP2636741A1 Induction of exon skipping in eukaryotic cells |
09/11/2013 | EP2636740A1 Induction of exon skipping in eukaryotic cells |
09/11/2013 | EP2636739A1 iRNA agents targeting VEGF |
09/11/2013 | EP2636738A1 Transformant of yeast of genus schizosaccharomyces and method for producing same |
09/11/2013 | EP2636737A1 Skin and hair color-controlling factor |
09/11/2013 | EP2636736A1 Novel anti-dr5 antibody |
09/11/2013 | EP2636735A1 Recombinant vaccinia virus having hemagglutinin protein genes derived from novel influenza viruses |
09/11/2013 | EP2636732A1 Sub-totipotent stem cell product and apparent hereditary modifying label thereof |
09/11/2013 | EP2636678A1 Derivatives of small interfering rnas and use thereof |
09/11/2013 | EP2635707A1 Method of examining polycystic kidney disease and method of screening for therapeutic agent of the disease |
09/11/2013 | EP2635696A2 Gardnerella vaginalis assay |
09/11/2013 | EP2635693A1 Methods for producing virus particles with simplified glycosylation of surface proteins |
09/11/2013 | EP2635688A1 Densovirus-derived vector for gene transfer in insects |
09/11/2013 | EP2635687A2 Modulation of immune responses by the poxviral k4 protein |
09/11/2013 | EP2635686A2 Neuronal specific targeting of caveolin expression to restore synaptic signaling and improve cognitive function in the neurodegenerative brain and motor function in spinal cord |
09/11/2013 | EP2635685A1 Method for increasing yield and fine chemical production in plants |
09/11/2013 | EP2635684A1 Plant expression system |
09/11/2013 | EP2635683A1 High amylose wheat |
09/11/2013 | EP2635682A1 Methods and vectors for cell immortalisation |
09/11/2013 | EP2635681A1 Base modified oligonucleotides |
09/11/2013 | EP2635680A2 Differential detection and quantification of oxalobacter |
09/11/2013 | EP2635679A1 Linking sequence reads using paired code tags |
09/11/2013 | EP2635678A1 Method of efficiently establishing induced pluripotent stem cells |
09/11/2013 | EP2635673A2 Biofuel and chemical production by recombinant microorganisms via fermentation of proteinacious biomass |
09/11/2013 | EP2635607A1 Stable heterodimeric antibody design with mutations in the fc domain |
09/11/2013 | EP2635594A1 Polypeptides having cellobiohydrolase activity and polynucleotides encoding same |
09/11/2013 | EP2635593A1 Vaccines for preventing meningococcal infections |
09/11/2013 | EP2635308A2 Compositions of a peptide targeting system for treating cancer |
09/11/2013 | EP2635294A1 Immunotherapy against erbb-3 receptor |
09/11/2013 | EP2635261A2 Compositions and methods for nanopolymer-based nucleic acid delivery |
09/11/2013 | EP2635108A2 Light-activated chimeric opsins and methods of using the same |
09/11/2013 | EP2635107A1 Papaver bracteatum with modified alkaloid content |
09/11/2013 | EP2635106A2 Soybean markers linked to scn resistance |
09/11/2013 | EP2635104A1 Stress-resistant plants and their production |
09/11/2013 | EP2570479A9 Recombinant bilirubin oxidase and production method for same |
09/11/2013 | CN1906296B Methods for the production of apolipoproteins in transgenic plants |
09/11/2013 | CN1906294B Improved protein expression systems |
09/11/2013 | CN1860226B Method of cleaving polypeptide by using OmpT protease mutant |
09/11/2013 | CN1842603B Method of selecting wt1 vaccine adaptive patient |
09/11/2013 | CN1826407B High titer recombinant influenza viruses for vaccines and gene therapy |
09/11/2013 | CN1678345B Multi plasmid system for the production of influenza virus |
09/11/2013 | CN103299179A Method for measuring pyrophosphoric acid and SNP-typing method |
09/11/2013 | CN103298953A Method for selecting fungus body and kit |
09/11/2013 | CN103298951A Method for detecting mutant dna |
09/11/2013 | CN103298946A Method for utilizing monoterpene glycosyltransferase |
09/11/2013 | CN103298943A Plants having enhanced yield-related traits and method for making the same |
09/11/2013 | CN103298942A Methods for transforming eukaryotic algae |
09/11/2013 | CN103298941A Treponema pallidum triplet antigen |
09/11/2013 | CN103298940A High amylose wheat |
09/11/2013 | CN103298939A Double stranded oligonucleotide compounds comprising positional modifications |
09/11/2013 | CN103298938A Nucleic acid construct for expressing oxidative stress indicator and use thereof |
09/11/2013 | CN103298937A Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor VIII |
09/11/2013 | CN103298936A Recombinant vaccinia virus having hemagglutinin protein genes derived from novel influenza viruses |
09/11/2013 | CN103298935A Compositions and methods for modifying properties of biologically active polypeptides |
09/11/2013 | CN103298934A Method for production of tumor cells from normal mammary epithelial cells |
09/11/2013 | CN103298931A Polypeptides having endoglucanase activity and polynucleotides encoding same |
09/11/2013 | CN103298929A Laccases and uses thereof |
09/11/2013 | CN103298834A Dual variable domain immunoglobulins and uses thereof |
09/11/2013 | CN103298829A DNA involved in gene expression regulation in photosynthetic tissue |
09/11/2013 | CN103298828A Genomics of actinoplanes utahensis |
09/11/2013 | CN103298359A Polypeptides having glucoamylase activity and polynucleotides encoding same |
09/11/2013 | CN103290144A Primer for detecting H7N9 subtype avian influenza virus infected by humans though RT-LAMP (reverse transcription loop-mediated isothermal amplification) and application of primer |
09/11/2013 | CN103290143A PCR composite reference object for detecting fowl tumour disease and preparation method thereof |
09/11/2013 | CN103290138A Real-time PCR (Polymerase Chain Reaction) rapid detection method of banana bunchy top viruses |
09/11/2013 | CN103290131A Primer pair and kit for distinguishing Channa argus and Channa maculata, and PCR-RFLP (polymerase chain reaction-restriction fragment length polymorphism) detection method |